Redeye: Addnode Q1 Preview - Minor revisions – Relatively low valuation
Redeye expects a stable Q1 report from Addnode, with mixed signals in different markets. The share is trading below our Base Case, which is rare from a historical perspective.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/